Spatiotemporal Delivery Strategies for Promoting Musculoskeletal Tissue Regeneration
暂无分享,去创建一个
[1] David J Mooney,et al. Quantitative assessment of scaffold and growth factor‐mediated repair of critically sized bone defects , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[2] J M Polak,et al. Scaffolds and biomaterials for tissue engineering: a review of clinical applications. , 2003, Clinical otolaryngology and allied sciences.
[3] Robert E Guldberg,et al. Sustained release of BMP-2 in a lipid-based microtube vehicle. , 2009, Acta biomaterialia.
[4] Linda G Griffith,et al. Engineering principles of clinical cell-based tissue engineering. , 2004, The Journal of bone and joint surgery. American volume.
[5] Jay R Lieberman,et al. The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.
[6] C. T. Wagner,et al. Evaluation criteria for musculoskeletal and craniofacial tissue engineering constructs: a conference report. , 2008, Tissue engineering. Part A.
[7] Ana Jaklenec,et al. Great expectations: private sector activity in tissue engineering, regenerative medicine, and stem cell therapeutics. , 2008, Tissue engineering. Part A.
[8] W. Hayes,et al. Bone regeneration by implantation of purified, culture‐expanded human mesenchymal stem cells , 1998, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[9] K. Anseth,et al. Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. , 2005, Acta biomaterialia.
[10] Anna Spagnoli,et al. Regenerative Effects of Transplanted Mesenchymal Stem Cells in Fracture Healing , 2009, Stem cells.
[11] A C Masquelet,et al. Induced membranes secrete growth factors including vascular and osteoinductive factors and could stimulate bone regeneration , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[12] V. Goldberg,et al. The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects* , 1998, The Journal of bone and joint surgery. American volume.
[13] S. Bhang,et al. Long-term delivery enhances in vivo osteogenic efficacy of bone morphogenetic protein-2 compared to short-term delivery. , 2008, Biochemical and biophysical research communications.
[14] H. Terai,et al. Optimized use of a biodegradable polymer as a carrier material for the local delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). , 2006, Biomaterials.
[15] Yinghua Su,et al. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: results of the NORTHERN trial. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.
[16] David J Mooney,et al. Designing scaffolds to enhance transplanted myoblast survival and migration. , 2006, Tissue engineering.
[17] M. Gebhardt,et al. Fractures of allografts. Frequency, treatment, and end-results. , 1990, The Journal of bone and joint surgery. American volume.
[18] M. Bostrom,et al. Potential Role of Bone Morphogenetic Proteins in Fracture Healing , 1998, Clinical orthopaedics and related research.
[19] R. Guldberg,et al. Biological effects of rAAV-caAlk2 coating on structural allograft healing. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[20] Eben Alsberg,et al. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. , 2004, Bone.
[21] A. Woolf,et al. Burden of major musculoskeletal conditions. , 2003, Bulletin of the World Health Organization.
[22] D. Biau,et al. Case Report: Reconstruction of a 16-cm Diaphyseal Defect after Ewing’s Resection in a Child , 2009, Clinical orthopaedics and related research.
[23] Sha Huang,et al. Release of bioactive BMP from dextran-derived microspheres: a novel delivery concept. , 2006, International journal of pharmaceutics.
[24] T. Clemens,et al. Activation of the hypoxia-inducible factor-1α pathway accelerates bone regeneration , 2008, Proceedings of the National Academy of Sciences.
[25] Richard Tuli,et al. Human mesenchymal progenitor cell-based tissue engineering of a single-unit osteochondral construct. , 2004, Tissue engineering.
[26] Robert M Nerem,et al. Tissue engineering: the hope, the hype, and the future. , 2006, Tissue engineering.
[27] Chao Wan,et al. Prolyl hydroxylase inhibitors increase neoangiogenesis and callus formation following femur fracture in mice , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[28] Peter Carmeliet,et al. Blood vessels and nerves: common signals, pathways and diseases , 2003, Nature Reviews Genetics.
[29] Chao Wan,et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. , 2007, The Journal of clinical investigation.
[30] Jueren Lou,et al. Evaluation of different scaffolds for BMP-2 genetic orthopedic tissue engineering. , 2005, Journal of biomedical materials research. Part B, Applied biomaterials.
[31] Robert E Guldberg,et al. Combination of platelet-rich plasma with polycaprolactone-tricalcium phosphate scaffolds for segmental bone defect repair. , 2007, Journal of biomedical materials research. Part A.
[32] Robert E Guldberg,et al. Recent advances in gene delivery for structural bone allografts. , 2007, Tissue engineering.
[33] A. Day,et al. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. , 2009, JAMA.
[34] D. Mooney,et al. Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[35] Timothy A. Miller,et al. BMP-2 exerts differential effects on differentiation of rabbit bone marrow stromal cells grown in two-dimensional and three-dimensional systems and is required for in vitro bone formation in a PLGA scaffold. , 2004, Experimental cell research.
[36] Bin Wang,et al. Activation of demineralized bone matrix by genetically engineered human bone morphogenetic protein-2 with a collagen binding domain derived from von Willebrand factor propolypeptide. , 2007, Journal of biomedical materials research. Part A.
[37] R. Bellamkonda,et al. Lipid-based microtubular drug delivery vehicles. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[38] Ann Sandison,et al. Comparison of the healing of open tibial fractures covered with either muscle or fasciocutaneous tissue in a murine model , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[39] L. Claes,et al. Moderate soft tissue trauma delays new bone formation only in the early phase of fracture healing , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[40] M. Swiontkowski,et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures. A subgroup analysis of data combined from two prospective randomized studies. , 2006, The Journal of bone and joint surgery. American volume.
[41] A. Reddi. Bone and cartilage differentiation. , 1994, Current opinion in genetics & development.
[42] O. Reikerås,et al. Influence of Extensive Muscle Injury on Fracture Healing in Rat Tibia , 2003, Journal of orthopaedic trauma.
[43] R. Cancedda,et al. Vascular endothelial growth factor (VEGF) in cartilage neovascularization and chondrocyte differentiation: auto-paracrine role during endochondral bone formation. , 2000, Journal of cell science.
[44] Di Chen,et al. Bone Morphogenetic Proteins , 2004, Growth factors.
[45] R. Guldberg,et al. Periosteal Progenitor Cell Fate in Segmental Cortical Bone Graft Transplantations: Implications for Functional Tissue Engineering , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[46] S. J. Lee. Cytokine delivery and tissue engineering. , 2000, Yonsei medical journal.
[47] Hiromu Ito,et al. Remodeling of cortical bone allografts mediated by adherent rAAV-RANKL and VEGF gene therapy , 2005, Nature Medicine.
[48] Robert E Guldberg,et al. Noninvasive image analysis of 3D construct mineralization in a perfusion bioreactor. , 2007, Biomaterials.
[49] L. Nordsletten. Recent developments in the use of bone morphogenetic protein in orthopaedic trauma surgery , 2006, Current medical research and opinion.
[50] A. Masquelet,et al. Muscle reconstruction in reconstructive surgery: soft tissue repair and long bone reconstruction , 2003, Langenbeck's Archives of Surgery.
[51] C. Laurencin,et al. Bone tissue engineering by gene delivery. , 2006, Advanced drug delivery reviews.
[52] K. Lyons,et al. Bone morphogenetic protein-2: biology and applications. , 1996, Clinical orthopaedics and related research.
[53] D. Stewart,et al. Effect of cell‐based VEGF gene therapy on healing of a segmental bone defect , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[54] D J Mooney,et al. Spatiotemporal control of vascular endothelial growth factor delivery from injectable hydrogels enhances angiogenesis , 2007, Journal of thrombosis and haemostasis : JTH.
[55] H. Redmond,et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[56] Michael J Yaszemski,et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. , 2009, Biomaterials.
[57] S D Cook,et al. Effect of recombinant human osteogenic protein-1 on healing of segmental defects in non-human primates. , 1995, The Journal of bone and joint surgery. American volume.
[58] Franz E Weber,et al. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. , 2005, Biotechnology and bioengineering.
[59] K. Siebenrock,et al. Long-term cell-mediated protein release from calcium phosphate ceramics. , 2009, Journal of biomedical materials research. Part A.
[60] M. Schaffler,et al. Prevention of fracture healing in rats by an inhibitor of angiogenesis. , 2001, Bone.
[61] J. Schmitt,et al. Bone morphogenetic proteins: An update on basic biology and clinical relevance , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.